Science Explorer Interactive view Map
Nonprofit · Rome · Italy

Fondazione Gimema Onlus

In research, Fondazione Gimema Onlus stands highest in Medicine (#12,573 of 17,978 worldwide) and Health Sciences (#15,748 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Medicine and Health Sciences — Medicine is 3.2× its share of world research.

gimema.itROR OpenAlex
World rank, all time
#34,523
of 42,892
Rank in Italy
#891
of 969
Research works
220
▲ 80% vs 2013–17
Citations
3.4k
15.4 per fractional work
Top-10% rate
20.5%
record average 16.5%
Open access
32%
world 28%

What is Fondazione Gimema Onlus known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #12,573 of 17,978 19.2%156
Health SciencesDomain #15,748 of 20,462 19.5%158

Each strip is that field’s whole ranked pool, with the notch where Fondazione Gimema Onlus sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Fondazione Gimema Onlus specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.2× the share of its output that it takes of world research.

  1. MedicineField · 22.1 works3.2×
  2. Health SciencesDomain · 22.7 works2.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.40× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.61× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 1.71× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 0.24× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.71× its world share, 0 worksChemistryComputer Science: 1.08× its world share, 3 worksComputer ScienceEnergy: 1.02× its world share, 0 worksEnergyEngineering: 0.45× its world share, 2 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.13× its world share, 0 worksMaterials ScienceMathematics: 0.46× its world share, 0 worksMathematicsPhysics and Astronomy: 0.08× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.65× its world share, 1 worksHealth ProfessionsMedicine: 3.23× its world share, 22 worksMedicineDecision Sciences: 0.10× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.32× its world share, 1 worksEconomics, Econometr…Psychology: 0.43× its world share, 0 worksPsychologySocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.2×. Every wedge is a field page.

Who are the top researchers at Fondazione Gimema Onlus?

Ranked on the composite score, Paola Fazi, Fabio Efficace and Tommaso Caravita lead among researchers whose main affiliation is Fondazione Gimema Onlus.

  1. 1 Paola Fazi Italy · #346,976 worldwide 83 citations · 28 works
  2. 2 Fabio Efficace Italy · #587,274 worldwide 85 citations · 45 works
  3. 3 Tommaso Caravita Italy · #594,585 worldwide 59 citations · 18 works
  4. 4 Alfonso Piciocchi Italy · #714,021 worldwide 44 citations · 34 works
  5. 5 Francesco Cottone Italy · #1,013,366 worldwide 21 citations · 15 works
All ranked researchers at Fondazione Gimema Onlus

Which keywords describe research at Fondazione Gimema Onlus?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Minimal Residual Disease, Acute Myeloid Leukemia, AML, Rituximab, Mutation and Genetic Alterations.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Prognostic Factors7▲ 44×7 topics
  2. Hematopoietic Stem Cells4▲ 114×2 topics
  3. Minimal Residual Disease3▲ 139×2 topics
  4. Machine Learning3▲ 2.7×11 topics
  5. AML3▲ 171×1 topic
  6. Acute Myeloid Leukemia3▲ 171×1 topic
  7. Rituximab3▲ 56×3 topics
  8. Deep Learning2▲ 1.96×8 topics
  9. Mutation2▲ 32×3 topics
  10. Genetic Alterations2▲ 77×2 topics
  11. BCR-ABL2▲ 210×1 topic
  12. Imatinib2▲ 210×1 topic
  13. Acute Lymphoblastic Leukemia2▲ 162×1 topic
  14. Childhood Cancer2▲ 162×1 topic
  15. Chronic Lymphocytic Leukemia2▲ 114×1 topic
  16. Genomic Aberrations2▲ 114×1 topic
  17. Lymphoma2▲ 32×3 topics
  18. Quality of Life2▲ 3.4×7 topics
  19. Diagnosis Criteria2▲ 117×1 topic
  20. International Myeloma Working Group2▲ 117×1 topic
  21. Proteasome Inhibitors2▲ 59×2 topics
  22. Classification1▲ 8.9×4 topics
  23. Health-related Quality of Life1▲ 15×2 topics
  24. PET Imaging1▲ 22×3 topics
  25. Epidemiology1▼ 0.77×13 topics
  26. Genetic Pathogenesis1▲ 60×1 topic
  27. Histopathology Images1▲ 35×1 topic
  28. Medical Image Analysis1▲ 17×1 topic
  29. Molecular Profiling1▲ 33×1 topic

Which research topics does Fondazione Gimema Onlus publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research and Chronic Lymphocytic Leukemia Research.

Acute Myeloid Leukemia R…3Acute Myeloid Leukemia Research: 3 fractional worksChronic Myeloid Leukemia Treatments: 2 fractional worksAcute Lymphoblastic Leuk…2Acute Lymphoblastic Leukemia research: 2 fractional worksChronic Lymphocytic Leuk…2Chronic Lymphocytic Leukemia Research: 2 fractional worksMultiple Myeloma Research and Treatments: 2 fractional worksAI in cancer detection: 1 fractional worksLymphoma Diagnosis and T…1Lymphoma Diagnosis and Treatment: 1 fractional worksMyeloproliferative Neoplasms: Diagnosis and Treatment: 1 fractional worksCancer survivorship and care: 1 fractional worksChildhood Cancer Survivors' Quality of Life: 1 fractional works
HematologyPublic Health, Environmental and Occupational HealthGeneticsArtificial Intelligence3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Myeloid Leukemia Research Hematology 3 works
  2. 2 Chronic Myeloid Leukemia Treatments Hematology 2 works
  3. 3 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 2 works
  4. 4 Chronic Lymphocytic Leukemia Research Genetics 2 works
  5. 5 Multiple Myeloma Research and Treatments Hematology 2 works
  6. 6 AI in cancer detection Artificial Intelligence 1 works
  7. 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  8. 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
  9. 9 Cancer survivorship and care Oncology 1 works
  10. 10 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.3%not open67.7%

World: 28% of research is openly available.

with international co-authors31.2%domestic only68.8%

World: 19% is written across borders.

How has Fondazione Gimema Onlus's research output changed?

Output in 2018–2022 was 80% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rome

All research institutions in Rome

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.